{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:35:09Z","timestamp":1767893709216,"version":"3.49.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p><jats:italic>Coxiella burnetii<\/jats:italic> is an obligate intracellular Gram-negative bacterium that causes acute and chronic Q fever in humans. Acute Q fever is usually a flu-like, self-limiting or treatable illness, but some infections can turn into a severe and sometimes fatal chronic disease. There is currently no FDA-approved vaccine available for the prevention of human Q fever in the US, development of a safe and effective vaccine for the prevention of human Q fever remains an important goal for public health. However, there is a fundamental gap in knowledge regarding the mechanism of protective immunity against <jats:italic>C. burnetii<\/jats:italic> infection. To understand the mechanism of <jats:italic>C. burnetii<\/jats:italic> infection induced protective immunity, we examined if <jats:italic>C. burnetii<\/jats:italic> Nine Mile phase I (NMI) infection induces protection against <jats:italic>C. burnetii<\/jats:italic> reinfection in mice. Our results indicate that NMI-infected mice conferred significant protection against <jats:italic>C. burnetii<\/jats:italic> reinfection. We also found that NMI infection derived protection did not depend on the routes of infection and antibodies are required for NMI infection derived protection. In addition, NMI infection elicited a comparable level of protection in Wild type, CD4<jats:sup>+<\/jats:sup> T cell deficient, and CD8<jats:sup>+<\/jats:sup> T cell deficient mice, partial protection in B cell deficient mice but no protection in T cell deficient mice. These results suggest that both B cells and T cells are required for NMI-infection derived protection, but T cells may play a critical role. Therefore, the new generation vaccine for the prevention of human Q fever should be focused on boosting both humoral and T cell immune responses.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1427822","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:51:36Z","timestamp":1728881496000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Coxiella burnetii Nine Mile phase I primary infection derived protective immunity against C. burnetii reinfection in mice depends on both B and T cells, but T cells play a critical role"],"prefix":"10.3389","volume":"15","author":[{"given":"Shawkat","family":"Alam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatesh","family":"Kumaresan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Palanisamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janakiram","family":"Seshu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68266-4","article-title":"Q fever","volume":"367","author":"Parker","year":"2006","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70052-9","article-title":"Natural history and pathophysiology of Q fever","volume":"5","author":"Raoult","year":"2005","journal-title":"Lancet Infect Diseases"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.18-0283","article-title":"Q fever in Southern California: a case series of 20 patients from a VA medical center","volume":"101","author":"Akamine","year":"2019","journal-title":"Am J Trop Med Hygiene"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.2.167","article-title":"Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine","volume":"159","author":"Raoult","year":"1999","journal-title":"Arch Intern Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131848","article-title":"Long-term serological follow-up of acute Q-fever patients after a large epidemic","volume":"10","author":"Wielders","year":"2015","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1089\/15303660260613747","article-title":"Q fever in humans and animals in the United States","volume":"2","author":"McQuiston","year":"2002","journal-title":"Vector Borne Zoonotic Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1099\/jmm.0.024778-0","article-title":"Q fever: the neglected biothreat agent","volume":"60","author":"Oyston","year":"2011","journal-title":"J Med Microbiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)91617-9","article-title":"Vaccine prophylaxis of abattoir-associated q fever","volume":"324","author":"Marmion","year":"1984","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: eight years\u2019 experience in Australian abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infection"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1994.tb125909.x","article-title":"Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990","volume":"160","author":"Ackland","year":"1994","journal-title":"Med J Aust"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00101-10","article-title":"Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii","volume":"78","author":"Read","year":"2010","journal-title":"Infect Immun"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01767-06","article-title":"T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect Immun"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00602-17","article-title":"Both major histocompatibility complex class i (mhc-i) and mhc-ii molecules are required, while mhc-i appears to play a critical role in host defense against primary coxiella burnetii Infection","volume":"86","author":"Buttrum","year":"2018","journal-title":"Infect Immun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a119894","article-title":"Protective or neutralizing antibody in Q fever","volume":"66","author":"Abinanti","year":"1957","journal-title":"Am J Hyg"},{"key":"B15","article-title":"Study of the antigenic structure of coxiella burneti. Iv. Phagocytosis and opsonization in relation to the phases of C. Burneti","volume":"9","author":"Brezina","year":"1965","journal-title":"Acta Virol"},{"key":"B16","article-title":"Phagocytosis of Coxiella burneti by macrophages","volume":"19","author":"Kaz\u00e1r","year":"1975","journal-title":"Acta Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1128\/iai.14.4.1087-1096.1976","article-title":"Electron microscopic study on the interaction between normal Guinea pig peritoneal macrophages and Coxiella burnetii","volume":"14","author":"Kishimoto","year":"1976","journal-title":"Infection immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB\/c mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"B19","volume-title":"Q Fever: The Biology of Coxiella Burneti","author":"Williams","year":"1991"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02826-10","article-title":"Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium","volume":"77","author":"Omsland","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754690","article-title":"The feasibility of using coxiella burnetii avirulent nine mile phase ii viable bacteria as a live attenuated vaccine against q fever","volume":"12","author":"Kumaresan","year":"2021","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00613-12","article-title":"Long-Term immune responses to Coxiella burnetii after vaccination","volume":"20","author":"Kersh","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00207","article-title":"Promiscuous coxiella burnetii CD4 epitope clusters associated with human recall responses are candidates for a novel T-cell targeted multi-epitope Q fever vaccine","volume":"10","author":"Scholzen","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007305","article-title":"Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques","volume":"14","author":"Cadena","year":"2018","journal-title":"PloS Pathog"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.idm.2018.06.002","article-title":"Infection-acquired versus vaccine-acquired immunity in an SIRWS model","volume":"3","author":"Leung","year":"2018","journal-title":"Infect Dis Model"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210454","article-title":"Sterilizing immunity: New opportunities for rational TB vaccine design","volume":"218","author":"Sher","year":"2021","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.11.6666-6675.2004","article-title":"Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections","volume":"72","author":"Brennan","year":"2004","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00042-15","article-title":"Neutrophils play an important role in protective immunity against Coxiella burnetii infection","volume":"83","author":"Elliott","year":"2015","journal-title":"Infect Immun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00297-13","article-title":"Formalin-inactivated Coxiella burnetii phase I vaccine-induced protection depends on B cells to produce protective IgM and IgG","volume":"81","author":"Zhang","year":"2013","journal-title":"Infect Immun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.coi.2018.04.011","article-title":"Antibody-based vaccine strategies against intracellular pathogens","volume":"53","author":"Casadevall","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1356540","DOI":"10.1155\/2019\/1356540","article-title":"Intracellular pathogens: host immunity and microbial persistence strategies","volume":"2019","author":"Thakur","year":"2019","journal-title":"J Immunol Res"},{"key":"B32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-94-007-4315-1_5","article-title":"Components of protective immunity","volume-title":"Coxiella burnetii: Recent Advances and New Perspectives in Research of the Q Fever Bacterium","author":"Zhang","year":"2012"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-19-3-281","article-title":"Antibody responses in acute and chronic Q fever and in subjects vaccinated against Q fever","volume":"19","author":"Worswick","year":"1985","journal-title":"J Med Microbiol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00376-19","article-title":"Eosinophils affect antibody isotype switching and may partially contribute to early vaccine-induced immunity against coxiella burnetii","volume":"87","author":"Ledbetter","year":"2019","journal-title":"Infect Immun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"Germann","year":"1995","journal-title":"Eur J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01695-14","article-title":"Characterization of a lipopolysaccharide-targeted monoclonal antibody and its variable fragments as candidates for prophylaxis against the obligate intracellular bacterial pathogen Coxiella burnetii","volume":"82","author":"Peng","year":"2014","journal-title":"Infect Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01073-15","article-title":"Role of B cells in host defense against primary Coxiella burnetii infection","volume":"83","author":"Schoenlaub","year":"2015","journal-title":"Infect Immun"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00824-19","article-title":"Major histocompatibility complex class ii-restricted, CD4(+) T cell-dependent and -independent mechanisms are required for vaccine-induced protective immunity against Coxiella burnetii","volume":"88","author":"Ledbetter","year":"2020","journal-title":"Infect Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro955","article-title":"Persistent bacterial infections: the interface of the pathogen and the host immune system","volume":"2","author":"Monack","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20021293","article-title":"Prevention of arthritis by interleukin 10-producing B cells","volume":"197","author":"Mauri","year":"2003","journal-title":"J Exp Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.22.012703.104622","article-title":"Interleukin-10 and related cytokines and receptors","volume":"22","author":"Pestka","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00045-16","article-title":"From Q fever to coxiella burnetii infection: a paradigm change","volume":"30","author":"Eldin","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.007","article-title":"Australia\u2019s national Q fever vaccination program","volume":"27","author":"Gidding","year":"2009","journal-title":"Vaccine"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.754712","article-title":"Coxiella burnetii whole cell vaccine produces a Th1 delayed-type hypersensitivity response in a novel sensitized mouse model","volume":"12","author":"Fratzke","year":"2021","journal-title":"Front Immunol"},{"key":"B45","article-title":"Guinea pig abscess\/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines","volume":"50","author":"Wilhelmsen","year":"2000","journal-title":"Comp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1427822\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T04:51:38Z","timestamp":1728881498000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1427822\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":45,"alternative-id":["10.3389\/fimmu.2024.1427822"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1427822","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]},"article-number":"1427822"}}